CERVINO
A Phase 3, Multicenter, Randomized, Open Label Study of Etentamig Compared With Standard Available Therapies in Subjects With Relapsed or Refractory Multiple Myeloma (3L+ RRMM Monotherapy Study)
Near Add Your Location
Sorting 41 by
- Accepting patients
University of Illinois at Chicago
Chicago, IL
- Accepting patients
- Accepting patients
Cedars-Sinai Medical Center - UCLA School of Medicine
Samuel Oschin Comprehensive Cancer Institute
Los Angeles, CA
- Accepting patients
- Accepting patients
- Accepting patients
Dana-Farber Cancer Institute
Boston, MA
- Accepting patients
- Accepting patients
- Accepting patients
Mayo Clinic (Rochester)
Rochester, MN
- Accepting patients
Real People. Real Support.
Need help connecting with this clinical trial? We're here to help!
Print a patient-friendly report to share with your patient.
We can help answer any questions and connect you (or your patient) with the study team.
Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.